发明名称 |
STABLE INJECTABLE PHARMACEUTICAL COMPOSITION OF NEUROKININ 1 RECEPTOR ANTAGONIST AND PROCESS FOR PREPARATION THEREOF |
摘要 |
The present invention relates to a controlled release sterile injectable formulation in the form of solution, suspension or sol-gel formulation for intramuscular or subcutaneous administration comprising a therapeutically effective amount of a neurokinin 1 receptor antagonist, in particular Aprepitant or Fosaprepitant or pharmaceutical acceptable salt, derivative or metabolite thereof. It also relates to a process for developing such formulations. |
申请公布号 |
US2015165045(A1) |
申请公布日期 |
2015.06.18 |
申请号 |
US201214412147 |
申请日期 |
2012.07.06 |
申请人 |
Karavas Evangelos;Koutris Efthimios;Bikiaris Dimitrios;Chatidou Sotiria;Diakidou Amalia;Barmpalexis Panagiotis;Konstanti Louiza;Minioti Katerina |
发明人 |
Karavas Evangelos;Koutris Efthimios;Bikiaris Dimitrios;Chatidou Sotiria;Diakidou Amalia;Barmpalexis Panagiotis;Konstanti Louiza;Minioti Katerina |
分类号 |
A61K47/38;A61K31/675;A61K47/34;A61K47/44;A61K47/14;A61K47/46;A61K31/5377;A61K9/00 |
主分类号 |
A61K47/38 |
代理机构 |
|
代理人 |
|
主权项 |
1. A controlled release pharmaceutical composition for intramuscular or subcutaneous administration comprising Aprepitant or Fosaprepitant or pharmaceutical acceptable salt, derivative or metabolite thereof, as the active ingredient, for the treatment of Chemotherapy Induced Nausea and Vomiting Syndrome. |
地址 |
Pallini Attikis GR |